{"id":229797,"date":"2026-01-25T23:20:19","date_gmt":"2026-01-26T05:20:19","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/01\/burden-of-central-nervous-system-cancer-in-the-united-states"},"modified":"2026-01-25T23:20:19","modified_gmt":"2026-01-26T05:20:19","slug":"burden-of-central-nervous-system-cancer-in-the-united-states","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/01\/burden-of-central-nervous-system-cancer-in-the-united-states","title":{"rendered":"Burden of Central Nervous System Cancer in the United States"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/burden-of-central-nervous-system-cancer-in-the-united-states.jpg\"><\/a><\/p>\n<p>While incidence rates for central nervous system cancer remained stable from 1990 to 2021, both mortality and disability-adjusted life-years (DALYs) declined. Disparities by geography, age, sex, and sociodemographic status highlight needs for targeted health policy reforms and resource redistribution.<\/p>\n<hr>\n<p>\n<strong>Findings<\/strong> In this cross-sectional study, analysis of the Global Burden of Disease Study 2021 data on US CNS cancers revealed that although the incidence rate remained relatively stable, both disability-adjusted life-years and mortality rates declined. However, substantial disparities persisted across geographical location, age, sex, and sociodemographic profile.<\/p>\n<p><strong>Meaning<\/strong> The persistent disparity in CNS cancer burden highlights the urgent need to reevaluate public health policies and redistribute health care resources to better support marginalized and underserved populations.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>While incidence rates for central nervous system cancer remained stable from 1990 to 2021, both mortality and disability-adjusted life-years (DALYs) declined. Disparities by geography, age, sex, and sociodemographic status highlight needs for targeted health policy reforms and resource redistribution. Findings In this cross-sectional study, analysis of the Global Burden of Disease Study 2021 data on [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1495,31,1901],"tags":[],"class_list":["post-229797","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-health","category-policy","category-sex"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/229797","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=229797"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/229797\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=229797"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=229797"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=229797"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}